Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Akt signaling is critical for memory CD8 + T-cell development and tumor immune surveillance
Anne Rogel, Jane E. Willoughby, Sarah L. Buchan, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 7
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID‐19
Qi‐Dong Xia, Yang Xun, Junlin Lu, et al.
Cell Proliferation (2020) Vol. 53, Iss. 12
Open Access | Times Cited: 208
The role of cytokines in T‐cell memory in health and disease
Miro E. Raeber, Yves Zurbuchen, Daniela Impellizzieri, et al.
Immunological Reviews (2018) Vol. 283, Iss. 1, pp. 176-193
Open Access | Times Cited: 178
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models
Dina Schneider, Ying Xiong, Darong Wu, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 586
Closed Access | Times Cited: 105
Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors
Jooeun Bae, Teru Hideshima, Yu‐Tzu Tai, et al.
Leukemia (2018) Vol. 32, Iss. 9, pp. 1932-1947
Open Access | Times Cited: 110
MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells
Zhong Zheng, Rui Sun, Huijin Zhao, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 88
Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy
Xin Lian, Kailin Yang, Renliang Li, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 69
Anti‐PD‐L1/TGF‐βR fusion protein (SHR‐1701) overcomes disrupted lymphocyte recovery‐induced resistance to PD‐1/PD‐L1 inhibitors in lung cancer
Bo Cheng, Kaikai Ding, Pengxiang Chen, et al.
Cancer Communications (2022) Vol. 42, Iss. 1, pp. 17-36
Open Access | Times Cited: 49
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results
Peter Schmid, Nicholas C. Turner, Carlos H. Barrios, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 4, pp. 767-778
Open Access | Times Cited: 26
Immunometabolism in cancer: basic mechanisms and new targeting strategy
Ranran Su, Yingying Shao, Manru Huang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 10
Covalent Plant Natural Product that Potentiates Antitumor Immunity
Misao Takemoto, Sara Delghandi, Masahiro Abo, et al.
Journal of the American Chemical Society (2025)
Closed Access | Times Cited: 1
Cancer stem cells: at the forefront of personalized medicine and immunotherapy
Micol Eleonora Fiori, Lidia Villanova, Ruggero De Maria
Current Opinion in Pharmacology (2017) Vol. 35, pp. 1-11
Closed Access | Times Cited: 52
Novel therapeutic avenues in triple-negative breast cancer: PI3K/AKT inhibition, androgen receptor blockade, and beyond
Jack Junjie Chan, Tira J. Tan, Rebecca Dent
Therapeutic Advances in Medical Oncology (2019) Vol. 11
Open Access | Times Cited: 48
Oral SMEDDS promotes lymphatic transport and mesenteric lymph nodes target of chlorogenic acid for effective T-cell antitumor immunity
Jun Ye, Yue Gao, Ming Ji, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002753-e002753
Open Access | Times Cited: 34
Integrated component identification, network pharmacology, and experimental verification revealed mechanism of Dendrobium officinale Kimura et Migo against lung cancer
Yan Zhao, Shuaitao Zhu, Yuan Li, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 243, pp. 116077-116077
Closed Access | Times Cited: 5
Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8+ T cells for adoptive immunotherapy
Charlotte M. Mousset, Willemijn Hobo, Yun Ji, et al.
OncoImmunology (2018) Vol. 7, Iss. 10, pp. e1488565-e1488565
Open Access | Times Cited: 44
FasL-PDPK1 Pathway Promotes the Cytotoxicity of CD8+ T Cells During Ischemic Stroke
Lizhen Fan, Cun‐Jin Zhang, Liwen Zhu, et al.
Translational Stroke Research (2020) Vol. 11, Iss. 4, pp. 747-761
Closed Access | Times Cited: 38
Diverse Roles of Akt in T cells
Leena Abdullah, L. Benjamin Hills, Evan B. Winter, et al.
Immunometabolism (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 30
VEGF-A enhances the cytotoxic function of CD4+ cytotoxic T cells via the VEGF-receptor 1/VEGF-receptor 2/AKT/mTOR pathway
Ziyi Chen, Meng Zhang, Yufeng Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Differential regulation of calcium-NFAT signaling pathway by Akt isoforms: unraveling effector dynamics and exhaustion of cytotoxic T lymphocytes in tumor microenvironment
Wen‐Ling Chen, Yong-Lin Chang, Su‐Fang Lin, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e009827-e009827
Open Access
Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment
Feifei Yang, Ting Hu, Jianquan Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114920-114920
Closed Access | Times Cited: 17
Comprehensive Analysis of the Immune Implication of ACK1 Gene in Non-small Cell Lung Cancer
Jinhong Zhu, Yang Liu, Haijiao Ao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 27
Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma
Kirit Singh, Kelly Hotchkiss, Kisha Patel, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5367-5367
Open Access | Times Cited: 23
Lack of Sprouty 1 and 2 enhances survival of effector CD8 + T cells and yields more protective memory cells
Hesham M. Shehata, Shahzada Khan, Elise Chen, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 38
Open Access | Times Cited: 26
Risk stratification for bladder cancer: Biomarkers of inflammation and immune activation
Reza Nabavizadeh, Katherine Bobrek, Viraj A. Master
Urologic Oncology Seminars and Original Investigations (2020) Vol. 38, Iss. 9, pp. 706-712
Closed Access | Times Cited: 19
Direct AKT activation in tumor-infiltrating lymphocytes markedly increases interferon-γ (IFN-γ) for the regression of tumors resistant to PD-1 checkpoint blockade
François Santinon, Bennani Fatima Ezzahra, Meriem Bachais, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top